Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Aeolus Pharmaceuticals Inc. (AOLS) had Return on Investments of -458.45% for the most recently reported fiscal quarter, ending 2017-06-30.
| Income Statement Financials | |
$0.01M |
|
$-0.95M |
|
-- |
|
$0.01M |
|
$0.96M |
|
$-0.95M |
|
-- |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
152.09M |
|
152.09M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.76M |
|
-- |
|
$0.03M |
|
$0.79M |
|
$0.59M |
|
-- |
|
-- |
|
$0.59M |
|
$0.21M |
|
$0.21M |
|
$0.21M |
|
152.09M |
|
| Cash Flow Statement Financials | |
$-2.75M |
|
-- |
|
-- |
|
$3.15M |
|
$0.40M |
|
$-2.75M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-7300.00% |
|
-7300.00% |
|
-- |
|
-7300.00% |
|
-7300.00% |
|
$-2.75M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.04 |
|
2166.92 |
|
-458.45% |
|
-458.45% |
|
-119.52% |
|
|
Return on Investments |
-458.45% |
$0.00 |
|
$-0.02 |
|
$-0.02 |
|